Janssen Pharmaceuticals Inc.

09/20/2020 | Press release | Distributed by Public on 09/20/2020 08:23

Janssen Presents Findings from Global, Multi-Center Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer